Mark has stated recently the company has seen success in their glyco program. I’d like to know the type of success they are seeing. In the gateway presentation around minutes 20-25 he talks more about the program. Very exciting stuff
Thanks for your insight as well. your views are consistently with another guy that i talked to who is a doctor "I don't see any obvious reason why the capability to glycoengineer to specs, either in C1 or as a post-secretory process that is performed on the C1 product, can not be achieved in time but I am not knowledgeable in the field. I don't see glycoengineering as make or break though, many other fish in the sea FWIW."